Evaluation of a New Homogeneous Immunoassay for Quantification of Prothrombin Fragment 1+2 (F1+2)

Mattthias Ehm
Siemens Healthineers
 |  01-07-2016

Prothrombin fragment F1+2 aids in the risk assessment of thrombosis and efficacy of anticoagulant treatment monitoring. Now for the first time, LOCI® technology* is being used to deliver an improved testing method for the measurement of F1+2. Watch a short video and learn how this assay has the potential to offer:

  • The first and only automated determination of F1+2
  • Excellent sensitivity and precision
  • A dynamic assay measuring range of up to 5000 pmol/L

Compartir esta página:

*Oxygen channeling technology.

Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.